Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A 24-week, Randomized, Open-label, Parallel Group Multinational Comparison of Lantus® (Insulin Glargine) Given in the Morning as Once-a-day Basal Insulin Versus Neutral Protamine Hagedorn (NPH) Insulin, in Children With Type 1 Diabetes Mellitus Aged at Least 1 Year to Less Than 6 Years

NCT00993473 is registered in ClinicalTrials.gov with Sanofi as lead sponsor.

NCT NCT00993473
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00993473 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A 24-week, Randomized, Open-label, Parallel Group Multinational Comparison of Lantus® (Insulin Glargine) Given in the Morning as Once-a-day Basal Insulin Versus Neutral Protamine Hagedorn (NPH) Insulin, in Children With Type 1 Diabetes Mellitus Aged at Least 1 Year to Less Than 6 Years
Lead sponsor
Sanofi
Phase
Phase 3
Overall status
Completed
Start date
October 31, 2009
Completion date
March 31, 2011
Enrollment
125 (actual)
Sites
61

Conditions

As the registry lists them; a condition with its own page is linked.

type 1 diabetes mellitus